Radiopharm Theranostics (ASX:RAD) has appointed Dr. Rama Abu Shmeis as Senior Vice President of Chemistry, Manufacturing, and Controls.
Dr. Shmeis has 23 years of experience in leading strategic, operational, and scientific aspects of CMC development and manufacturing through all clinical stages to commercialization.
She has also led successful global regulatory CMC submissions, approvals, and market launches across multiple therapeutic areas.